These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31897458)

  • 1. Organometallic nucleoside analogues: effect of the metallocene metal atom on cancer cell line toxicity.
    Ismail MK; Armstrong KA; Hodder SL; Horswell SL; Male L; Nguyen HV; Wilkinson EA; Hodges NJ; Tucker JHR
    Dalton Trans; 2020 Jan; 49(4):1181-1190. PubMed ID: 31897458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Regiochemistry and Methylation on the Anticancer Activity of a Ferrocene-Containing Organometallic Nucleoside Analogue.
    Ismail MK; Khan Z; Rana M; Horswell SL; Male L; Nguyen HV; Perotti A; Romero-Canelón I; Wilkinson EA; Hodges NJ; Tucker JHR
    Chembiochem; 2020 Sep; 21(17):2487-2494. PubMed ID: 32255248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide Bioconjugates of Electron-Poor Metallocenes: Synthesis, Characterization, and Anti-Proliferative Activity.
    Maschke M; Grohmann J; Nierhaus C; Lieb M; Metzler-Nolte N
    Chembiochem; 2015 Jun; 16(9):1333-42. PubMed ID: 26012853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship of trifluoromethyl-containing metallocenes: electrochemistry, lipophilicity, cytotoxicity, and ROS production.
    Maschke M; Alborzinia H; Lieb M; Wölfl S; Metzler-Nolte N
    ChemMedChem; 2014 Jun; 9(6):1188-94. PubMed ID: 24838930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships.
    Wang R; Chen H; Yan W; Zheng M; Zhang T; Zhang Y
    Eur J Med Chem; 2020 Mar; 190():112109. PubMed ID: 32032851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties.
    Mu C; Prosser KE; Harrypersad S; MacNeil GA; Panchmatia R; Thompson JR; Sinha S; Warren JJ; Walsby CJ
    Inorg Chem; 2018 Dec; 57(24):15247-15261. PubMed ID: 30495936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferrocenyl and organic novobiocin derivatives: Synthesis and their in vitro biological activity.
    Mbaba M; Mabhula AN; Boel N; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
    J Inorg Biochem; 2017 Jul; 172():88-93. PubMed ID: 28441548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrocene-appended pharmacophores: an exciting approach for modulating the biological potential of organic scaffolds.
    Singh A; Lumb I; Mehra V; Kumar V
    Dalton Trans; 2019 Feb; 48(9):2840-2860. PubMed ID: 30663743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
    Peter S; Aderibigbe BA
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organometallic nucleoside analogues with ferrocenyl linker groups: synthesis and cancer cell line studies.
    Nguyen HV; Sallustrau A; Balzarini J; Bedford MR; Eden JC; Georgousi N; Hodges NJ; Kedge J; Mehellou Y; Tselepis C; Tucker JH
    J Med Chem; 2014 Jul; 57(13):5817-22. PubMed ID: 24905419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, spectroscopic investigation, and DFT study of N,N'-disubstituted ferrocene-based thiourea complexes as potent anticancer agents.
    Asghar F; Fatima S; Rana S; Badshah A; Butler IS; Tahir MN
    Dalton Trans; 2018 Feb; 47(6):1868-1878. PubMed ID: 29337321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
    Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
    Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the antitumor activity of a cyclopalladated ferrocene compound assisted by a dual-targeting drug delivery system.
    Gong G; Cao Y; Qian H; Zhou Y; Zhao H; Li L; Wang F; Zhao G
    Chem Commun (Camb); 2018 Jul; 54(60):8312-8315. PubMed ID: 29868665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferrocene-Containing Impiridone (ONC201) Hybrids: Synthesis, DFT Modelling, In Vitro Evaluation, and Structure⁻Activity Relationships.
    Bárány P; Oláh RS; Kovács I; Czuczi T; Szabó CL; Takács A; Lajkó E; Láng O; Kőhidai L; Schlosser G; Bősze S; Mező G; Hudecz F; Csámpai A
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30177664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular disruption of lysosomal targeting organometallic polyarginine bioconjugates.
    Gross A; Alborzinia H; Piantavigna S; Martin LL; Wölfl S; Metzler-Nolte N
    Metallomics; 2015 Feb; 7(2):371-84. PubMed ID: 25608481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organometallic anticancer agents: the effect of the central metal and halide ligands on the interaction of metallocene dihalides Cp2MX2 with nucleic acid constituents.
    Murray JH; Harding MM
    J Med Chem; 1994 Jun; 37(13):1936-41. PubMed ID: 8027975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition.
    Mbaba M; de la Mare JA; Sterrenberg JN; Kajewole D; Maharaj S; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
    J Biol Inorg Chem; 2019 Mar; 24(2):139-149. PubMed ID: 30542925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the Anticancer Action of Novel Ferrocene Analogues of MNK Inhibitors.
    Sansook S; Lineham E; Hassell-Hart S; Tizzard GJ; Coles SJ; Spencer J; Morley SJ
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30142961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of nucleoside analogues: a density functional theory based QSAR study.
    Sarmah P; Deka RC
    J Mol Model; 2010 Mar; 16(3):411-8. PubMed ID: 19626352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New carbocyclic nucleoside analogues with a bicyclo[2.2.1]heptane fragment as sugar moiety; synthesis, X-ray crystallography and anticancer activity.
    Tănase CI; Drăghici C; Căproiu MT; Shova S; Mathe C; Cocu FG; Enache C; Maganu M
    Bioorg Med Chem; 2014 Jan; 22(1):513-22. PubMed ID: 24280070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.